We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current ALDX market cap is 193.1M. The company's latest EPS is USD -0.6319 and P/E is -5.14.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -16.8M | -10.34M | -9.55M | -6.1M | -9.39M |
| Net Income | -15.62M | -8.99M | -8.19M | -4.75M | -8.08M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -63.07M | -36.42M | -56.22M | -62.68M | -42.8M |
| Net Income | -60.83M | -37.55M | -57.78M | -62.03M | -37.54M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 168.22M | 155.62M | 147.28M | 148.33M | 141.3M |
| Total Liabilities | 30.98M | 25.73M | 24.27M | 28.53M | 27.88M |
| Total Equity | 137.24M | 129.88M | 123.01M | 119.8M | 113.42M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 75.52M | 83.35M | 233.14M | 181.29M | 148.33M |
| Total Liabilities | 27.44M | 23.84M | 27.4M | 30.28M | 28.53M |
| Total Equity | 48.08M | 59.51M | 205.74M | 151.01M | 119.8M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -9.44M | -22.8M | -30.83M | -30.33M | -9.97M |
| Investing | 30M | 30M | 30M | 30M | -30.38M |
| Financing | 53k | 58k | -257k | -1.27M | 18k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -44.98M | -37.49M | -42.56M | -56.64M | -30.33M |
| Investing | 18.48M | 29.02M | -8k | -29.95M | 30M |
| Financing | 23.58M | 41.9M | 194.5M | 1.22M | -1.27M |
| Market Cap | 193.1M |
| Price to Earnings Ratio | -5.14 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 1.35 |
| Price to Book Ratio | 1.61 |
| Dividend Yield | - |
| Shares Outstanding | 59.41M |
| Average Volume (1 week) | 358.4k |
| Average Volume (1 Month) | 307.57k |
| 52 Week Change | -53.84% |
| 52 Week High | 8.54 |
| 52 Week Low | 1.42 |
| Spread (Intraday) | 0.16 (4.69%) |
| Company Name | Aldeyra Therapeutics Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.aldeyra.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
